Mascarenhas L, van Beek A, Bennink H C, Newton J
Academic Department of Obstetrics and Gynaecology, Birmingham Women's Hospital, UK.
Hum Reprod. 1998 Nov;13(11):3057-60. doi: 10.1093/humrep/13.11.3057.
The objectives of this study were to evaluate the endometrial histology and cervical cytology of users of two contraceptive implants releasing etonogestrel/3-keto-desogestrel (Implanon) and levonorgestrel (Norplant) in West Midlands (UK) users. A 2-year prospective randomized design was used to study 60 implant users. Endometrial histology and cervical cytology were compared before insertion and after 12 and 24 months. At the end of 12 months, the majority of samples were inactive/weakly proliferative in both groups. At the end of 24 months, this remained unchanged in the Implanon group whereas the pattern was more diverse in the Norplant group. Endometrial thickness was significantly reduced in both groups during treatment. Cervical cytology remained unchanged. It is concluded that, after 2 years, there was no evidence of an increasing risk of endometrial hyperplasia, endometrial carcinoma, cervical intra-epithelial neoplasia or cervical carcinoma in either of the two groups of implant users.
本研究的目的是评估在西米德兰兹郡(英国)使用两种释放依托孕烯/3-酮去氧孕烯(依伴侬)和左炔诺孕酮(诺普兰)的避孕植入剂使用者的子宫内膜组织学和宫颈细胞学情况。采用为期2年的前瞻性随机设计,对60名植入剂使用者进行研究。比较了植入前以及12个月和24个月后的子宫内膜组织学和宫颈细胞学情况。在12个月末,两组中的大多数样本均呈静止/轻度增殖状态。在24个月末,依伴侬组的情况保持不变,而诺普兰组的模式则更多样化。治疗期间两组的子宫内膜厚度均显著降低。宫颈细胞学情况保持不变。得出的结论是,两年后,两组植入剂使用者均没有证据表明子宫内膜增生、子宫内膜癌、宫颈上皮内瘤变或宫颈癌的风险增加。